摘要
文章就与牙周相关的糖原贮积病研究进展做一介绍,即糖原贮积病Ⅰb型的发病机制、口腔与全身临床表现、诊断、临床管理及口腔管理,以期为口腔临床医生提供相关罕见疾病的诊疗思路。
This article mainly introduces the pathogenesis,oral and systemic clinical manifestations,diagnosis,clinical and oral management of glycogen storage disease Ⅰb,in order to provide clinical philosophy of relevant diseases for dentists.
引文
[1]梁翠丽.糖原累积病Ⅰ型基因突变分析与临床关系研究[D].广州:广州医科大学,2013.
[2]袁裕衡,刘妍,邱正庆.3例糖原累积症Ⅰb型SLC37A4基因分析[J].临床儿科杂志,2017,35(3):179-182.
[3]Chou JY,Matern D,Mansfield BC,et al.TypeⅠglycogen storage diseases:disorders of the glucose-6-phosphatase complex[J].Curr Mol Med,2002,2(2):121-143.
[4]Chou JY,Jun HS,Mansfield BC.Neutropenia in typeⅠb glycogen storage disease[J].Curr Opin Hematol,2010,17(1):36-42.
[5]Boztug K,Appaswamy G,Ashikov A,et al.A syndrome with congenital neutropenia and mutations in G6PC3[J].N Engl J Med,2009,360(1):32-43.
[6]Bartoli A,BossùM,Sfasciotti G,et al.Glycogen storage disease typeⅠb:a paediatric case report[J].Eur J Paediatr Dent,2006,7(4):192-198.
[7]Ma R,Moein Vaziri F,Sabino G,et al.Glycogen storage diseaseⅠb and severe periodontal destruction:a case report[J].Dent J(Basel),2018,6(4):E53.
[8]Duplan MB,Hubert A,Norcy EL,et al.Dental and periodontal manifestations of glycogen storage diseases:a case series of 60patients[J].J Inherit Metab Dis,2018,41(6):947-953.
[9]Cheung YY,Kim SY,Yiu WH,et al.Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta[J].J Clin Invest,2007,117(3):784-793.
[10]Kim SY,Jun HS,Mead PA,et al.Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease typeⅠb[J].Blood,2008,111(12):5704-5711.
[11]Kishnani PS,Austin SL,Abdenur JE,et al.Diagnosis and management of glycogen storage disease typeⅠ:a practice guideline of the American College of Medical Genetics and Genomics[J].GenetMed,2014,16(11):e1.
[12]Angaroni CJ,Labrune P,Petit F,et al.Glycogen storage disease typeⅠb without neutropenia generated by a novel splice-site mutation in the glucose-6-phosphate translocase gene[J].Mol Genet Metab,2006,88(1):96-99.
[13]邱正庆,卢超霞,王薇,等.糖原累积症Ⅰb型15家系SLC37A4基因分析研究[J].中华儿科杂志,2011,49(3):203-208.
[14]Bhattacharya K,Orton RC,Qi X,et al.A novel starch for the treatment of glycogen storage diseases[J].J Inherit Metab Dis,2007,30(3):350-357.
[15]Maheshwari A,Rankin R,Segev DL,et al.Outcomes of liver transplantation for glycogen storage disease:a matched-control study and a review of literature[J].Clin Transplant,2012,26(3):432-436.
[16]Martens DH,Rake JP,Navis G,et al.Renal function in glycogen storage disease typeⅠ,natural course,and renopreservative effects of ACE inhibition[J].Clin J Am Soc Nephrol,2009,4(11):1741-1746.
[17]Li AM,Thyagu S,Maze D,et al.Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length[J].Pediatr Hematol Oncol,2018,35(1):45-51.
[18]Mortellaro C,Garagiola U,Carbone V,et al.Unusual oral manifestations and evolution in glycogen storage disease typeⅠb[J].J Craniofac Surg,2005,16(1):45-52.
[19]Kawai T.Anesthetic management for an emergency operation in a patient with von Gierke disease[J].Masui,2005,54(8):924-925.
[20]Giannitrapani L,Soresi M,La SE,et al.Sex hormones and risk of liver tumor[J].Ann N Y Acad Sci,2010,1089(1):228-236.
[21]Martens DH,Rake JP,Schwarz M,et al.Pregnancies in glycogen storage disease typeⅠa[J].Am J Obstet Gynecol,2008,198(6):646.e1-e7.